Aixin Life director Xinliang Li resigns from board

Aixin Life International, Inc. reported that, effective May 18, 2026, board member Mr. Xinliang Li, also known as Christopher Lee, resigned from the Board of Directors.

Accepted by SEC EDGAR 05/18/2026 - 04:15 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Aixin Life International, Inc. reported that, effective May 18, 2026, board member Mr. Xinliang Li, also known as Christopher Lee, resigned from the Board of Directors. He previously served on the Compensation Committee, Nominating and Corporate Governance Committee, and was Chair of the Audit Committee.

The company states that Mr. Lee’s resignation was not due to any disagreement with the company regarding its operations, policies, or practices, including financial matters. The filing also includes standard cautionary language about forward-looking statements related to planned acquisitions and future performance.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Effective resignation date: May 18, 2026

1 metrics

Effective resignation date May 18, 2026 Director Xinliang Li’s board resignation effective date

Key Terms

forward-looking statements, Emerging growth company, Audit Committee, Compensation Committee, +1 more

5 terms

forward-looking statements regulatory

"Cautionary Note Regarding Forward-Looking Statements Any statements contained in this ..."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

Emerging growth company regulatory

"405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"

An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.

Audit Committee financial

"Mr. Lee was a member of the Company’s Compensation Committee, Nominating and Corporate Governance Committee and the Chair of its Audit Committee."

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

Compensation Committee financial

"Mr. Lee was a member of the Company’s Compensation Committee, Nominating and Corporate Governance Committee and the Chair of its Audit Committee."

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

Nominating and Corporate Governance Committee financial

"Mr. Lee was a member of the Company’s Compensation Committee, Nominating and Corporate Governance Committee and the Chair of its Audit Committee."

A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board change did AIXIN Life International, Inc. (AIXN) disclose?

Aixin Life International, Inc. disclosed that director Mr. Xinliang Li, also known as Christopher Lee, resigned from its Board of Directors effective May 18, 2026. He also left the Compensation, Nominating and Corporate Governance, and Audit Committees, where he had served as Chair of the Audit Committee.

Did AIXIN (AIXN) report any disagreement related to the director’s resignation?

The company states that Mr. Li’s resignation was not due to any disagreement with Aixin Life International, Inc. on operations, policies, or practices, financial or otherwise. This language is intended to signal that no underlying dispute or conflict triggered his departure from the board.

What committee roles did Mr. Xinliang Li hold at AIXIN (AIXN)?

Mr. Li served on the Compensation Committee and the Nominating and Corporate Governance Committee, and was the Chair of the Audit Committee. His resignation therefore affects several key oversight functions, particularly financial reporting and governance responsibilities handled by the Audit Committee.

When did the director resignation at AIXIN (AIXN) become effective?

The resignation of director Mr. Xinliang Li became effective on May 18, 2026. The same date appears on the company’s report, indicating the change in board composition and committee leadership took effect immediately as of that day.

Does AIXIN (AIXN) mention forward-looking statements in this report?

Yes. The company includes a cautionary note regarding forward-looking statements, covering expectations about planned acquisitions, purchase prices, and future performance. It explains these statements involve risks and uncertainties and are based on management’s beliefs and expectations as of the report date only.

What stock exchange does AIXIN Life International, Inc. (AIXN) trade on?

The company’s common stock trades under the symbol AIXN on the OTCQX market. This information appears in the section listing securities registered under Section 12(b) of the Securities Exchange Act, along with the title of the registered class.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false 0000835662 0000835662 2026-05-18 2026-05-18 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): May 18, 2026

AIXIN LIFE INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Colorado		0-17284		84-1085935
State of		Commission		IRS Employer
Incorporation		File Number		Identification No.

Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China 00000

(Address of principal executive offices)

86-313-6732526

(Issuer’s telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock		AIXN		OTCQX

Cautionary Note Regarding Forward-Looking Statements:

Any statements contained in this Current Report on Form 8-K that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are generally identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans to,” “estimates,” “projects,” or similar expressions. Such statements may include, but are not limited to, statements about the Company’s planned acquisitions, the purchase price to be paid for such acquisitions and the future performance of the businesses to be acquired, and other statements that are not historical facts. Such statements are based upon the beliefs and expectations of the Company’s management as of this date only and are subject to risks and uncertainties that could cause actual results to differ materially. Therefore, investors are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by applicable law.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective May 18, 2026, Aixin Life International, Inc. (the “Company”) accepted the resignation of Mr. Xinliang Li a/k/a Christopher Lee from the Company’s Board of Directors. Mr. Lee was a member of the Company’s Compensation Committee, Nominating and Corporate Governance Committee and the Chair of its Audit Committee. Corporate Mr. Lee’s resignation was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices (financial or otherwise). The Company provided a copy of this Report on Form 8-K to Mr. Lee prior to its filing with the Securities and Exchange Commission.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AiXin Life International, Inc.
Date: May 18, 2026	By:	/s/ Quanzhong Lin
		Quanzhong Lin
		Chief Executive Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB